An Act to repeal 632.865 (2) and 632.865 (5) (e); to renumber 632.865 (4); to amend 40.51 (8), 40.51 (8m), 66.0137 (4), 120.13 (2) (g), 185.983 (1) (intro.), 609.83, 632.861 (4) (a), 632.865 (1) (ae) and 632.865 (6) (c) 3.; and to create 632.861 (1m), 632.861 (3g), 632.861 (3r), 632.861 (4) (e), 632.862, 632.865 (1) (ab) and (ac), 632.865 (1) (an), (aq), and (at), 632.865 (1) (bm), 632.865 (1) (cg) and (cr), 632.865 (2d), 632.865 (2h), 632.865 (2p), 632.865 (2t), 632.865 (4) (b), 632.865 (5d), (5h), (5p) and (5t), 632.865 (6) (bm), 632.865 (6) (c) 3m., 632.865 (6g), 632.865 (6r) and 632.865 (8) of the statutes; Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| Date / House | Action | Journal |
|---|---|---|
| 12/1/2023 Sen. | Introduced by Senators Felzkowski, Quinn, James, Pfaff and Taylor; cosponsored by Representatives Schraa, Rozar, Tittl, Conley, Considine, Dittrich, Donovan, Edming, Goeben, Goyke, Gundrum, Jacobson, Magnafici, Mursau, Novak, O'Connor, Oldenburg, Palmeri, Snyder, Tusler and Wichgers | |
| 12/1/2023 Sen. | Read first time and referred to Committee on Insurance and Small Business | |
| 12/4/2023 Sen. | Representative Rettinger added as a cosponsor | |
| 12/6/2023 Sen. | Public hearing held | |
| 12/6/2023 Sen. | Senator Larson added as a coauthor | |
| 12/11/2023 Sen. | Fiscal estimate received | |
| 12/13/2023 Sen. | Representative Baldeh added as a cosponsor | |
| 12/28/2023 Sen. | Representative Green added as a cosponsor | |
| 12/28/2023 Sen. | Representative O'Connor withdrawn as a cosponsor | |
| 1/17/2024 Sen. | Representative Armstrong added as a cosponsor | |
| 2/6/2024 Sen. | Representative Allen added as a cosponsor | |
| 4/15/2024 Sen. | Failed to pass pursuant to Senate Joint Resolution 1 |
